Trastuzumab Recruiting Phase 2 Trials for Central Nervous System Metastases / HER2-positive Metastatic Breast Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03417544Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC